Association between baseline-stratified trajectory subgroups of serum albumin and outcomes in critically ill patients with early sepsis-associated acute kidney injury: a retrospective study - Report - MDSpire
Advertisement
Association between baseline-stratified trajectory subgroups of serum albumin and outcomes in critically ill patients with early sepsis-associated acute kidney injury: a retrospective study
Clinical Report: Serum Albumin Trajectories and Outcomes in Early SA-AKI
Overview
This study investigates the relationship between serum albumin trajectories and clinical outcomes in critically ill patients with early sepsis-related acute kidney injury (SA-AKI). Five distinct trajectory subgroups of serum albumin levels were identified.
Background
Sepsis is a major public health issue with high mortality rates, particularly in intensive care unit (ICU) patients. Sepsis-associated acute kidney injury (SA-AKI) complicates the clinical course and is linked to poor outcomes.
Data Highlights
Trajectory Group
Albumin Level (g/dL)
Mortality Risk
Hospital LOS
Steady-state
2.0
Increased mortality risk
Longer LOS
Steady-state
3.0
Reference
Reference
Steady-state
4.1+
Increased 365-day mortality risk
N/A
Key Findings
Five baseline-stratified trajectory subgroups of serum albumin levels were identified.
Patients with a steady-state trajectory at 2.0 g/dL had significantly higher mortality risks at 30, 90, 180, and 365 days compared to the 3.0 g/dL group.
Patients with a trajectory level of >4.1 g/dL exhibited increased 365-day mortality risk.
Longer hospital length of stay was associated with lower albumin levels.
Age and sex interacted with the association between serum albumin trajectories and mortality risk.
Clinical Implications
Monitoring serum albumin trajectories in critically ill patients with early SA-AKI may provide insights for risk stratification.
Conclusion
The study highlights the association of serum albumin trajectories with mortality risk and hospital length of stay in critically ill patients with early SA-AKI.